HealthQuill Drugs
Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats
Drugs Health Pharma

Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats

Eli Lilly and Company cut the prices of its weight-loss drug  Zepbound, available in single-dose vials, in a bid to end compounding companies from.

Read More
Regeneron Pharmaceuticals, Inc.’s investigational gene therapy improved hearing in 10 out of 11 children born with hearing loss because of gene mutation, according to a company statement.
Drugs Health Medical

Regeneron’s trial therapy improves hearing in children with gene mutations

Regeneron Pharmaceuticals, Inc.’s investigational gene therapy improved hearing in 10 out of 11 children born with hearing loss because of gene mutation, according.

Read More
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency for Research on Cancer, a specialised arm of the World Health Organization.
Drugs Health Pharma

Breast cancer death rates globally to rise 68% by 2050: WHO arm IARC warns

Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.

Read More
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
Drugs Health Medical

US regulator clears Mirum’s oral drug for reducing cholesterol deposits

Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.

Read More
artificial sweeteners are harmful to our health
Drugs Health

Artificial sweeteners spike insulin levels, increasing risk of heart diseases

HQ Team February 21, 2025: Artificial sweeteners, long used as low-calorie alternatives to sugar, are known to cause a number of health conditions,.

Read More
FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing the Anglo-Swedish firm to gain access to an anaemia drug in the world’s most populated nation.
Drugs Health Pharma

AstraZeneca Plc buys China unit of FibroGen Inc for $160 million

HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.

Read More
NCD cause of 81 percent deaths in under 70 says report
Drugs Health Research

28% of elderly Indians prescribed potentially harmful medications: Study

HQ Times February 19, 2025: A new study has revealed that 28 out of every 100 elderly individuals in India are being prescribed.

Read More
Merck & Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours, and who had prior treatment, has been “conditionally” approved by the European Commission, according to a company statement.
Drugs Health Medical

EC grants ‘conditional’ nod for Merck’s drug to treat VHL disease

HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.

Read More
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to the Massachusetts-based firm.
Drugs Health Medical

Bain Capital to buy Japan’s Mitsubishi Tanabe Pharma for $3.3 billion

Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Pharma

AbbVie’s drug-resistant abdominal infection medicine gets US nod

HQ Team February 10, 2025: The U.S. Food and Drug Administration (FDA) has approved Emblaveo, a new antibiotic combination of aztreonam and avibactam,.

Read More